Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
David Kent, LMT, NCTMB
David Kent is an international presenter, product innovator and writer with a clinic, the Muscular Pain Relief Center, in Deltona, Fla. He is also president and founder of Kent Health Systems.